Raymond James Financial (RJF) news
Recent news
ASML Holding N.V.: Citigroup raises target price to EUR 2300 from EUR 2200
Citigroup has raised its price target for ASML Holding N.V. (ASML) to EUR 2,300 from EUR 2,200, reflecting a positive outlook on the company’s performance and growth prospects. This adjustment aligns with broader analyst sentiment, as the average price target for ASML has increased to $2,396 from…
AInvest Wire · 2h agoSeaport Therapeutics Inc: Canaccord Genuity initiates coverage with buy rating; price target $28
Canaccord Genuity has initiated coverage on Seaport Therapeutics, Inc. (SPTX) with a "Buy" rating and a price target of $28 , according to a report dated October 14, 2026. This recommendation comes amid recent developments in the company’s clinical pipeline, including the Phase 1 clinical data for…
AInvest Wire · 17h agoWeatherford International PLC: Raymond James cuts target price to $115 from $122
Raymond James has adjusted its price target for Weatherford International PLC (WFRD), reducing it to $115 from $122, while maintaining an 'Outperform' rating. This marks a further downward revision from the previous target of $125 set earlier in the year. The move reflects ongoing analyst…
AInvest Wire · 20h agoJ&J: Raymond James cuts target price to $278 from $280
Raymond James has adjusted its price target for Johnson & Johnson (JNJ), reducing it to $278 from the previous $280, according to recent analyst activity . The move reflects ongoing evaluations of the company’s performance amid mixed results across its business segments. While the pharmaceutical…
AInvest Wire · 20h agoFB Financial Corporation: Raymond James cuts target price to $62 from $65
AInvest Wire · 20h agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
